SERUM URIC ACID LEVELS AND THEIR ASSOCIATION WITH MYOCARDIAL INFARCTION OUTCOMES
Main Article Content
Keywords
Coronary artery disease,Serum uric acid, Cardiovascular events, Vasodilator, Xanthine Oxidase, Myocardial Infarction
Abstract
Clinical and epidemiological studies have proved that serum uric acid (SUA) is significantly correlated with cardiovascular disease. The present study has been undertaken with the following High uric acid level is a negative prognostic factor in patients with myocardial infarction. In myocardial infarction higher the uric acid level increases the risk of mortality rate. There is uncertainty about the role. This prospective study evaluated the relationship between serum uric acid (SUA) levels and clinical outcomes in 100 patients with acute myocardial infarction (MI). SUA levels were measured on admission, and patients were monitored for heart failure, arrhythmias, ejection fraction, and mortality. The mean SUA level was 5.9 mg/dl, with males having higher levels than females. Patients with SUA levels above 7 mg/dl had significantly lower ejection fractions and poorer Killip classifications. Among patients in Killip class IV, 12 out of 15 had SUA levels above 7 mg/dl, and 4 died from arrhythmias and hypotension. Additionally, patients with ventricular tachycardia (VT) had SUA levels exceeding 7 mg/dl and experienced in-hospital mortality. No significant differences in SUA levels were found between diabetic and non-diabetic patients. The study concludes that elevated SUA at admission is a strong, independent predictor of short-term adverse outcomes, including mortality, in MI patients. SUA measurement can be a cost-effective tool for early risk stratification and guiding treatment strategies.f uric acid in acute coronary syndrome and whether it could be used as a prognostic marker in MI patients. The role of serum uric acid in cardiovascular and renal diseases has been intensively investigated. High serum uric acid has been indicated as a risk factor for CAD and as an independent prognostic factor of poorer outcomes in patients with verified CAD. Study was done in one hundred patients of myocardial infarction at Sri Venkateshwaraa Medical College Hospital and Research Centre, Pondicherry.Detailed history and clinical examination done. Uric acid was estimated. The relationship of uric acid with severity of Myocardial infarction, treatment response, ejection fraction, arrhythmia and hypotension were studied. A total of 100 patients were recruited to the study. The mean age and mean uric acid level of the study sample was 56 years and 5.9mg/dl respectively. There were 65(65%) males and 35(35%) females. Males had higher uric acid level than females. (p<0.05). Those who had SUA >7mg/dl (n= 17) had low ejection fraction which was statistically significant p value ,0.03. Among the 15 patients belonging to KILLIP IV, 12 had SUA values more than 7 mg/dL.(, p <0.05.). Measuring serum uric acid level at admission for acute Myocardial infarction patients we can stratify them and can treat effectively. Uric acid is a strong risk factor for myocardial infarction and stroke.
References
2. Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004;20:369-79.
3. Cicoira M, Zanolla L, Rossi A, Elevated Serum Uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy . Am Heart J 2002:143; 1107-11.
4. Olexa P, Olexova M, Gonsorcik J, et al. Uric acid a marker for systemic inflammatory response in patients with congestive heart failure? Wien KIin Wochenschr 2002;28:211–15.
5. Bickel C, Rupprecht HJ, Blankenberg S,Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89:12-7.
6. Ochiai ME, Barretto AC, Oliveira MT. Uric acid renal excretion and renal in sufficiency in decompensated severe heart failure. Eur J Heart Fail 2005;7:468–74.
7. Kroll K, Bukowski TR, Schwartz LM, Knoepfler D, Bassingthwaighte JB. Capillary endothelial transport of uric acid in guinea pig heart. Am J Physiol 1992, 262:H420-31
8. Castelli P, Condemi AM, Brambillasca C,. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol 1995;25:119–25.
9. Kogure K, Ishizaki M, Nemoto M, Evaluation of serum uric acid changes in different forms of hepatic vascular inflow occlusion in human liver surgeries. Life Sci 1999;64:305–13.
10. Anker SD, Doehner W, Rauchhaus M,. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and haemodynamic staging. Circulation 2003;22:1991–97.
11. Johnson RJ, Rodriguez-Iturbe B, Kang DH. A unifying pathway for essential hypertension. Am J Hypertens 2005;18:431-40.
12. Tuomilheto J, Zimmet P, Evawolf. Plasma Uric acid level and its association with Diabetes Mellitus and some Biologic Parameters in a Biracial Population of FIJI Am J Epidemiol 1988;127:32136.
13. Safi AJ, Mahmood R, Khan MA, Haq A. Association of serum Uric Acid with type II diabetes mellitus. J Postgrad Med Inst 2004;18:59-63.
14. Pietro Cirillo, Waichi Sato, Sirirat Reungjui,Marcelo Heinig, Michael Gersch, Yuri Sautin, Takahiko Nakagawa and Richard J. Johnson. Uric Acid, the Metabolic Syndrome, and Renal Disease. JASN.17:12 suppl 3 S165-S168.
15. Kojima S, Sakamoto T, Ishihara M,. Prognostic usefulness of serum uric acid after acute myocardial infarction (Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005;96: 489-95.
16. Nadkar MY, Jain VI. Serum Uric Acid in Acute Myocardial Infarction. J Assoc Physicians India. 2008: 56:759-62.
17. Vladimir Trkulja and Siniša Carl Croat Med J. Apr 2012; 53(2): 162–172.
18. Ersan Tatli, Meryem Aktoz, Mutlu Buyuklu and Armagan Altun Cardiology Journal 2008; 15;1: 21–25.
19. Hongyu Zhang, Hongyu Wang, Xiaoli Chen, Chuanshi Xiao heart.bmj.com, Heart 2011;97:A99.
20. Leonardo Tamariz, MD, MPH, Sunil Agarwal, MD, MPH, Elsayed Z. Soliman, MD, MSc, MS, Alanna M. Chamberlain, PhD, Ronald Prineas, MD, PhD, Aaron R. Folsom, MD, MPH, Marietta Ambrose, MD, and Alvaro Alonso, MD,PhD Am J Cardiol.
21. Yuansheng LiuPeking. Hyperurecemia and risk of atrial fibrillation. Journal of Atrial Fibrillation Feb-mar 2014 volume 6 issue 5
22. Filippo Valbusa, MD Lorenzo Bertolini, MD Stefano Bonapace, MD Luciano Zenari, MD Giacomo Zoppini, MD Guido Arcaro,MD Christopher D. Byrne, MD Giovanni Targher, MD American Journal of Cardiology 112, 4, 499–504, 15, 2013.
23. Yildiz A, Yilmaz R, Demirbag R, Gur M, Bas MM, Association of serum uric acid level and coronary blood flow. Coron Artery Dis. 2007; 18: 607-613